GlassScriptPhysician profile
Parastou Fatemi
NPI 1366806002
$5,733.21
in general payments reported to CMS, 2019-2025
7 companies · $295 in 2025
The $295 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $429 · 2023: $1,714 · 2024: $3,296 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,403 · Food and Beverage: $1,902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,402.72 |
| Food and Beverage | $1,901.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,139.07 | 2022-2024 | Aero-Ll, N/A, Cascadia Interbody System |
| Globus Medical, INC. | $1,889.05 | 2024-2025 | Excelsiusgps Robotic Navigation System, Elsa, Rise |
| Medtronic, INC. | $330.21 | 2022-2023 | Stealthstation S8 Platform |
| Nuvasive, INC. | $149.05 | 2023 | Simplify Cervical Artificial Disc |
| Mml US, INC. | $102.72 | 2024 | Reactiv8 |
| Si-Bone, INC. | $89.63 | 2023 | |
| Spineology INC. | $33.48 | 2024 | Optimesh Expandable Interbody Fusion System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parastou Fatemi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.